Xid and Xid-like immunodeficiencies from a signaling point of view

Current Opinion in Immunology

Volumn 9, Issue 3, 1997, Pages 319-323

  Tarakhovsky, Alexander ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE RECEPTOR; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

B LYMPHOCYTE; ENZYME PHOSPHORYLATION; GENE TARGETING; IMMUNE DEFICIENCY; MAST CELL; REVIEW;

EID: 0030740453     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80076-3     Document Type: Article

References (50)

1. Tsukada S, Rawlings DJ, Witte ON. Role of Bruton's tyrosine kinase in immunodeficiency. Curr Opin Immunol. 6:1994;623-630.
2. Smith CIE, Islam KB, Vorechovsky I, Olerup O, Wallin E, Rabbani H, Baskin B, Hammarstrsm L. X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol Rev. 138:1994;159-183.
3. Khan WN, Alt FW, Gerstein RM, Malynn BA, Larsson I, Rathbun G, Davidson L, Muller S, Kantor AB, Herzenberg LA, et al. Defective B cell development and function in Btk-deficient mice. of outstanding interest Immunity. 3:1995;283-299 This study addresses the reason of much less severe immunodeficiency in xid mice as compared to XLA. In order to find whether the severity of Xid could be changed by additional alterations in Btk gene, the authors have generated Btk-deficient mice. Practically indistinguishable immunodeficiencies in Btk-deficient and xid mice suggest that severity of Xid is not dependent on the location of mutation. This study provides a comprehensive comparative analysis of the immune systems in xid and Btk-deficient mice.
4. Santos-Argumedo L, Lund FE, Heath AW, Solvason N, Wu WW, Grimaldi JC, Parkhouse RM, Howard M. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction. of special interest Int Immunol. 7:1995;163-170 Describes for the first time the alteration of CD38-mediated proliferation of xid B cells.
5. Miyake K, Yamashita Y, Hitoshi Y, Takatsu K, Kimoto M. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J Exp Med. 180:1994;1217-1224.
6. Hitoshi Y, Sonoda E, Kikuchi Y, Yonehara S, Nakauchi H, Takatsu H. IL-5 receptor positive B cells, but not eosinophils, are functionally and numerically influenced in mice carrying the X-linked immune defect. Int Immunol. 5:1993;1183-1190.
7. Go NF, Castle BE, Barret R, Kastelein R, Dang W, Mosmamm TR, Moore KW, Howard M. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med. 172:1990;1625-1631.
8. Rawlings DJ, Scharenberg AM, Park H, Wahl MI, Lin S, Kato RM, Fluckiger AC, Witte ON, Kinet JP. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. of outstanding interest Science. 271:1996;822-825 Demonstrates the two-step mechanism of Btk tyrosine phosphorylation by Src-like kinases for the first time and reveals the exact position of phosphorylated tyrosines in Btk.
9. Vihinen M, Iwata T, Kinnon C, Kwan SP, Ochs HD, Vorechovsky I, Smith CI. BTK base, mutation database for X-linked agammaglobulinemia (XLA). of special interest Nucleic Acids Res. 24:1996;160-165 Very helpful compendium of Btk mutations.
10. Takata M, Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. of special interest J Exp Med. 184:1996;31-40 This study demonstrates a diminished PLC-γ2 activation in Btk-deficient chicken lymphoma cells and suggests the cooperation between Btk and Syk in phosphorylation of PLC-γ2.
11. Park H, Wahl MI, Afar DE, Turck CW, Rawlings DJ, Tam C, Scharenberg AM, Kinet JP, Witte ON. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. of outstanding interest Immunity. 4:1996;515-525 The gain-of-function mutant of Btk carries a point mutation in the PH domain that results in constitutive phosphorylation and increased membrane localization of the protein. Using this form of Btk the authors demonstrate the distinctive role of the phosphorylation of Y221 and Y551 residues (single-letter amino acid code) in Btk function.
12. Li T, Tsukada S, Satterthwaite A, Havlik MH, Park H, Takatsu K, Witte ON. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. of outstanding interest Immunity. 2:1995;451-460 This study demonstrates that a single amino acid substitution in the PH domain of Btk (E41K) results in the constitutive activation of Btk. The mutated Btk becomes oncogenic for fibroblasts and induces the IL-5-independent growth of originally IL-5-dependent pro-B cells. Also suggests the direct correlation between membrane association and activation of Btk.
13. cbl in the negative regulation of tyrosine kinase signaling.
14. cbl interaction in vivo leaves the question about the physiological relevance of this interaction open.
15. Rawlings D, Witte ON. The Btk subfamily of cytolasmic tyrosine kinases: structure, regulation and function. Semin Immunol. 7:1995;237-246.
16. Bunnell SC, Henry PA, Kolluri R, Kirchhausen T, Rickles RJ, Berg LJ. Identification of Itk/Tsk Src homology 3 domain ligands. of outstanding interest J Biol Chem. 271:1996;25646-25656 Demonstrates binding of Itk to Wiscott-Aldrich syndrome protein and suggests the Wiscott-Aldrich syndrome protein-Btk interaction.
17. Weiss A, Littman. Signal transduction by lymphocyte antigen receptors. Cell. 76:1994;263-274.
18. Cheng G, Ye ZS, Baltimore D. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc Natl Acad Sci USA. 91:1994;8152-8155.
19. Lowell CA, Soriano P. Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories. of special interest Gen Devel. 10:1996;1845-1857 The most 'fresh' update on the phenotypes of mice deficient for various Src-like kinases.
20. Pao LI, Bedzyk WD, Persin C, Cambier JC. Molecular targets of CD45 in B cell antigen receptor signal transduction. of special interest J Immunol. 158:1997;1116-1124 Demonstrates the reduction of Btk phosphorylation in CD45-deficient myeloma cells. Confirms an important role of Src-like kinases in Btk phosphorylation.
21. Afar DE, Park H, Howell BW, Rawlings DJ, Cooper J, Witte ON. Regulation of Btk by Src family tyrosine kinases. of special interest Mol Cell Biol. 16:1996;3465-3471 Demonstrates the binding of purified SH3 domains of several Src-like kinases to the consensus region within the TH domain of Btk. Provides the structural basis for Btk activation by Src-like kinases.
22. Saouaf SJ, Mahajan S, Rowley RB, Kut SA, Fargnoli J, Burkhardt AL, Tsukada S, Witte ON, Bolen JB. Temporal differences in the activation of three classes of non transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc Natl Acad Sci USA. 91:1994;9524-9528.
23. Thomas JD, Sideras P, Smith CI, Vorechovsky I, Chapman V, Paul WE. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science. 261:1993;355-358.
24. Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M, Copeland NG, et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 261:1993;358-361.
25. Kawakami Y, Yao L, Miura T, Tsukada S, Witte ON, Kawakami T. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking. Mol Cell Biol. 14:1994;5108-5113.
26. Harlan JE, Hajduk PJ, Yoon HS, Fesik SW. Pleckstrin homology domains bind to phosphatidylinositol-4,5-biphosphate. Nature. 371:1994;168-170.
27. Ferguson KM, Lemmon MA, Schlessinger J, Sigler PB. Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain. of outstanding interest Cell. 83:1995;1037-1046 Suggests the role of the PH domain in membrane association of PH-domain-containing proteins.
28. Fukuda M, Kojima T, Kabayama H, Mikoshiba K. Mutation in the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity. of special interest J Biol Chem. 271:1996;30303-30306 Compares the binding of various phospholipids to the wild-type and mutated froms of the PH domain of Btk. Explains an increased membrane association of mutated Btk (E41K) by increased affinity of the mutated protein to phospholipids.
29. Yao L, Kawakami Y, Kawakami T. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci USA. 91:1994;9175-9179.
30. Tsukada S, Simon MI, Witte ON, Katz A. Binding of beta gamma subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase. Proc Natl Acad Sci USA. 91:1994;11256-11260.
31. Langhans-Rajasekaran SA, Wan Y, Huang XY. Activation of Tsk and Btk tyrosine kinases by G protein beta gamma subunits. of special interest Proc Natl Acad Sci USA. 92:1995;8601-8605 Demonstrates the regulation of Btk activity by G proteins.
32. Baixeras E, Kroemer G, Cuende E, Marques C, Bosca L, Martinez C. Signal transduction pathways involved in B-cell induction. Immunol Rev. 132:1993;5-42.
33. Kawakami Y, Yao L, Gibson S, Mills GB, Kawakami T. Activation and interaction with protein kinase C of a cytoplasmic tyrosine kinase, Itk/Tsk/Emt, on FcεeRI cross-linking on mast cells. of special interest J Immunol. 155:1995;3556-3562 Provides further support for the role of PKC in the regulation of Btk-like kinases.
34. Sidorenko SP, Law C-L, Klaus SJ, Chandran KA, Takata M, Kurosaki T, Clark EA. Protein kinase Cμ (PKCμ) associates with the B cell antigen receptor complex and regulates lymphocyte signalling. of special interest Immunity. 5:1996;353-363 Demonstrates the association of PKCμ with BCR and suggests potentially important role of this protein in BCR signaling.
35. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stabel S, Tarakhovsky A. Immunodeficiency in protein linase Cβ-deficient mice. Science. 273:1996;788-791.
36. Lund FE, Yu N, Kim KM, Reth M, Howard MC. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. of special interest J Immunol. 157:1996;1455-1467 Demonstrates the involvement of BCR-associated signaling molecules in CD38-mediated signaling.
37. Miyake K, Yamashita Y, Ogata M, Sudo T, Kimoto M. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. of special interest J Immunol. 154:1995;3333-3340 Describes the structure of RP105 protein. Very important study in view of the regulatory role of RP105 in IgM-mediated apoptosis of mature B cells.
38. + B cells. Immunol Rev. 137:1994;91-118.
39. Kantor AB, Stall AM, Adams S, Watanabe K, Herzenberg LA. De novo development and self-replenishment of B cells. Int Immunol. 7:1995;55-68.
40. Rickert RC, Rajewsky K, Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. of outstanding interest Nature. 376:1995;352-355 See annotation [41].
41. Ahearn JM, Fisher MB, Croix D, Goerg S, Ma M, Xia J, Zhou X, Howard RG, Rothstein TL, Carroll MC. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependnet antigen. of outstanding interest Immunity. 4:1996;251-262 This paper, along with [40], demonstrates an essential role of CD19/CD21 complex in the development or maintenance of B-1 cells. Reveals the difference in CD19 contribution for the T-cell-dependent and -independent B cell responses.
42. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. of special interest Nature. 374:1995;470-473 See annotation [43].
43. Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz VLJ. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. of special interest Nature. 374:1995;467-470 This paper, along with [42], demonstrates the critical role of Vav in antigen-receptor-mediated proliferation of B and T cells.
44. Fearon DT, Carter RH. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol. 13:1995;127-150.
45. Doody GM, Dempsey PW, Fearon DT. Activation of B lymphocytes: integrating signals from CD19, CD22 and FcγRIIb1. Curr Opin Immunol. 8:1996;378-382.
46. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo X. Phosphotyrosine-dependent activation of rac-1 GDP/GTP exchange by vav protooncogene product. of outstanding interest Nature. 385:1997;169-172 Resolves the long lasting problem about the substrate specificity of the Dbl-like domain of Vav. Demonstrates the role of Vav in the regulation of GDP/GTP exchange in the small G protein Rac in a very elegant way.
47. Weng W-K, Jarvis L, LeBien TW. Signalling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem. 269:1994;32514-32521.
48. Conley ME, Parolini O, Rohrer J, Campana D. X-linked agammaglobulinemia: new approaches to old questions based on the identification of the defective gene. Immunol Rev. 138:1994;5-21.
49. Conley ME, Rohrer J. The spectrum of mutations in Btk that cause X-linked agammaglobulinemia. of special interest Clin Immunol Immunopathol. 76:1995;S192-S197 A comprehensive compendium of mutations within the Btk locus.
50. Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald J, Neel DA, Rito CJ, Singh U, Stramm LE, Melikian-Badalian A, et al. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-dione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta. of special interest J Med Chem. 39:1996;2664-2671 Describes the structure and properties of a selective inhibitor of PKCβ.